The global kainic acid market is expected to grow at a significant CAGR during the forecast period. Kainic acid is a cyclic analogue of L-glutamate that binds to ionotropic kainic acid receptors and acts as an agonist. It was isolated and extracted from digenea simplex, red algae occurring in tropical and sub-tropical water. It was originally known as digenic acid; however, the name was changed to kainic acid to prevent confusion with other digenea derivatives. Kainic acid was developed as an ascaricide to treat ascariasis, a disease caused by ascaris lumbricoides. The temporal lobe epilepsy model based on kainic acid has significantly supported the understanding of the molecular, cellular, and pharmacological mechanisms underlying epileptogenesis and ictogenesis. 

Excitotoxicity plays a role in several central nervous system (CNS) neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Kainic acid (KA), an excitotoxic glutamate analogue, can cause selective neuronal death in rodents’ brains, with pathological alterations which mimic neurodegeneration in the CNS. As a result, KA-induced neurotoxicity in rodents has been used to investigate the pathogenesis of excitotoxicity in neurodegenerative diseases.

The neuropathological and electroencephalographic properties of this model are similar to those found in patients with temporal lobe epilepsy.  Epilepsy is the most common neurological condition, according to the World Health Organization (WHO), with a prevalence of over 50 million people and an annual incidence of 2.4 million. The most prevalent type of partial epileptic disorder is temporal lobe epilepsy (TLE), which accounts for 60% of all cases. This rising prevalence of epilepsy disorder around the globe is expected to drive the global kainic acid market. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment covered

• Competitive Landscape- Glentham Life Sciences, R&D Systems, Abcam plc, and Others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Kainic Acid Market Segmentation 

By Type

• Low Purity (Below 97%)
• Purity (Above 97% and below 99%)
• High Purity (Above 99%)

By Application

• Epilepsy Treatment
• Neurological Research
• Others

Global Kainic Acid Market By Region